skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma

Abstract

Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the largest sequencing study of osteosarcoma to date, comprising 112 childhood and adult tumours encompassing all major histological subtypes. A key finding of our study is the identification of mutations in insulin-like growth factor (IGF) signalling genes in 8/112 (7%) of cases. We validate this observation using fluorescence in situ hybridization (FISH) in an additional 87 osteosarcomas, with IGF1 receptor (IGF1R) amplification observed in 14% of tumours. These findings may inform patient selection in future trials of IGF1R inhibitors in osteosarcoma. Analysing patterns of mutation, we identify distinct rearrangement profiles including a process characterized by chromothripsis and amplification. This process operates recurrently at discrete genomic regions and generates driver mutations. Lastly, it may represent an age-independent mutational mechanism that contributes to the development of osteosarcoma in children and adults alike.

Authors:
 [1];  [2]; ORCiD logo [3];  [4];  [2]; ORCiD logo [5];  [6];  [2]; ORCiD logo [7];  [2];  [2];  [2];  [8];  [2];  [2];  [2];  [2];  [2];  [2];  [9] more »;  [10]; ORCiD logo [2];  [11];  [12];  [13];  [13]; ORCiD logo [14];  [15];  [15]; ORCiD logo [16];  [2];  [9];  [1] « less
  1. Wellcome Trust Genome Campus, Cambridgeshire (United Kingdom); Univ. of Cambridge, Cambridge (United Kingdom)
  2. Wellcome Trust Genome Campus, Cambridgeshire (United Kingdom)
  3. The Francis Crick Institute, London (United Kingdom)
  4. Royal National Orthopaedic Hospital, Middlesex (United Kingdom)
  5. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  6. Wellcome Trust Genome Campus, Cambridgeshire (United Kingdom); UCL Great Ormond Street Institute of Child Health, London (United Kingdom)
  7. Wellcome Trust Center for Human Genetics, Oxford (United Kingdom)
  8. UCL Great Ormond Street Institute of Child Health, London (United Kingdom)
  9. Royal National Orthopaedic Hospital NHS Trust, Middlesex (United Kingdom); Univ. College London Cancer Institute, London (United Kingdom)
  10. The Hospital for Sick Children, Toronto, ON (Canada)
  11. Wellcome Trust Genome Campus, Cambridgeshire (United Kingdom); Univ. of Texas, Houston, TX (United States)
  12. Univ. of Basel, Basel (Switzerland)
  13. Oslo Univ. Hospital, Oslo (Norway)
  14. Oslo Univ. Hospital, Oslo (Norway); Univ. of Bergen, Bergen (Norway)
  15. Royal National Orthopaedic Hospital NHS Trust, Middlesex (United Kingdom)
  16. The Francis Crick Institute, London (United Kingdom); Univ. of Leuven, Leuven (Belgium)
Publication Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE Laboratory Directed Research and Development (LDRD) Program
OSTI Identifier:
1372794
Report Number(s):
LA-UR-16-27671
Journal ID: ISSN 2041-1723
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 8; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES; Biological Science

Citation Formats

Behjati, Sam, Tarpey, Patrick S., Haase, Kerstin, Ye, Hongtao, Young, Matthew D., Alexandrov, Ludmil B., Farndon, Sarah J., Collord, Grace, Wedge, David C., Martincorena, Inigo, Cooke, Susanna L., Davies, Helen, Mifsud, William, Lidgren, Mathias, Martin, Sancha, Latimer, Calli, Maddison, Mark, Butler, Adam P., Teague, Jon W., Pillay, Nischalan, Shlien, Adam, McDermott, Ultan, Futreal, P. Andrew, Baumhoer, Daniel, Zaikova, Olga, Bjerkehagen, Bodil, Myklebost, Ola, Amary, M. Fernanda, Tirabosco, Roberto, Van Loo, Peter, Stratton, Michael R., Flanagan, Adrienne M., and Campbell, Peter J. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. United States: N. p., 2017. Web. doi:10.1038/ncomms15936.
Behjati, Sam, Tarpey, Patrick S., Haase, Kerstin, Ye, Hongtao, Young, Matthew D., Alexandrov, Ludmil B., Farndon, Sarah J., Collord, Grace, Wedge, David C., Martincorena, Inigo, Cooke, Susanna L., Davies, Helen, Mifsud, William, Lidgren, Mathias, Martin, Sancha, Latimer, Calli, Maddison, Mark, Butler, Adam P., Teague, Jon W., Pillay, Nischalan, Shlien, Adam, McDermott, Ultan, Futreal, P. Andrew, Baumhoer, Daniel, Zaikova, Olga, Bjerkehagen, Bodil, Myklebost, Ola, Amary, M. Fernanda, Tirabosco, Roberto, Van Loo, Peter, Stratton, Michael R., Flanagan, Adrienne M., & Campbell, Peter J. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. United States. doi:10.1038/ncomms15936.
Behjati, Sam, Tarpey, Patrick S., Haase, Kerstin, Ye, Hongtao, Young, Matthew D., Alexandrov, Ludmil B., Farndon, Sarah J., Collord, Grace, Wedge, David C., Martincorena, Inigo, Cooke, Susanna L., Davies, Helen, Mifsud, William, Lidgren, Mathias, Martin, Sancha, Latimer, Calli, Maddison, Mark, Butler, Adam P., Teague, Jon W., Pillay, Nischalan, Shlien, Adam, McDermott, Ultan, Futreal, P. Andrew, Baumhoer, Daniel, Zaikova, Olga, Bjerkehagen, Bodil, Myklebost, Ola, Amary, M. Fernanda, Tirabosco, Roberto, Van Loo, Peter, Stratton, Michael R., Flanagan, Adrienne M., and Campbell, Peter J. Fri . "Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma". United States. doi:10.1038/ncomms15936. https://www.osti.gov/servlets/purl/1372794.
@article{osti_1372794,
title = {Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma},
author = {Behjati, Sam and Tarpey, Patrick S. and Haase, Kerstin and Ye, Hongtao and Young, Matthew D. and Alexandrov, Ludmil B. and Farndon, Sarah J. and Collord, Grace and Wedge, David C. and Martincorena, Inigo and Cooke, Susanna L. and Davies, Helen and Mifsud, William and Lidgren, Mathias and Martin, Sancha and Latimer, Calli and Maddison, Mark and Butler, Adam P. and Teague, Jon W. and Pillay, Nischalan and Shlien, Adam and McDermott, Ultan and Futreal, P. Andrew and Baumhoer, Daniel and Zaikova, Olga and Bjerkehagen, Bodil and Myklebost, Ola and Amary, M. Fernanda and Tirabosco, Roberto and Van Loo, Peter and Stratton, Michael R. and Flanagan, Adrienne M. and Campbell, Peter J.},
abstractNote = {Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the largest sequencing study of osteosarcoma to date, comprising 112 childhood and adult tumours encompassing all major histological subtypes. A key finding of our study is the identification of mutations in insulin-like growth factor (IGF) signalling genes in 8/112 (7%) of cases. We validate this observation using fluorescence in situ hybridization (FISH) in an additional 87 osteosarcomas, with IGF1 receptor (IGF1R) amplification observed in 14% of tumours. These findings may inform patient selection in future trials of IGF1R inhibitors in osteosarcoma. Analysing patterns of mutation, we identify distinct rearrangement profiles including a process characterized by chromothripsis and amplification. This process operates recurrently at discrete genomic regions and generates driver mutations. Lastly, it may represent an age-independent mutational mechanism that contributes to the development of osteosarcoma in children and adults alike.},
doi = {10.1038/ncomms15936},
journal = {Nature Communications},
number = ,
volume = 8,
place = {United States},
year = {2017},
month = {6}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 19 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Osteosarcoma treatment – Where do we stand? A state of the art review
journal, May 2014


Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
journal, December 2014

  • Perry, Jennifer A.; Kiezun, Adam; Tonzi, Peter
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 51
  • DOI: 10.1073/pnas.1419260111

Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
journal, April 2014


Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
journal, December 2015

  • Kovac, Michal; Blattmann, Claudia; Ribi, Sebastian
  • Nature Communications, Vol. 6, Issue 1
  • DOI: 10.1038/ncomms9940

Landscape of somatic mutations in 560 breast cancer whole-genome sequences
journal, May 2016

  • Nik-Zainal, Serena; Davies, Helen; Staaf, Johan
  • Nature, Vol. 534, Issue 7605
  • DOI: 10.1038/nature17676

Signatures of mutational processes in human cancer
journal, August 2013

  • Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.
  • Nature, Vol. 500, Issue 7463
  • DOI: 10.1038/nature12477

Insulin, insulin-like growth factors and neoplasia
journal, August 2008


M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
journal, December 1995

  • De Souza, Angus T.; Hankins, Gerald R.; Washington, Mary K.
  • Nature Genetics, Vol. 11, Issue 4
  • DOI: 10.1038/ng1295-447

Development of IGF-IR inhibitors in pediatric sarcomas
journal, June 2009


Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program
journal, May 2010

  • Kolb, E. Anders; Gorlick, Richard; Houghton, Peter J.
  • Pediatric Blood & Cancer, Vol. 55, Issue 4
  • DOI: 10.1002/pbc.22576

Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-β as Involved in the Pathogenesis of Osteosarcoma
journal, October 2015

  • Yang, Rui; Piperdi, Sajida; Zhang, Yue
  • Clinical Orthopaedics and Related Research®, Vol. 474, Issue 1
  • DOI: 10.1007/s11999-015-4578-1

Insulin-Like Growth Factor 1 Receptor and Response to Anti-IGF1R Antibody Therapy in Osteosarcoma
journal, August 2014


IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
journal, May 2013

  • Kuijjer, Marieke L.; Peterse, Elisabeth FP; van den Akker, Brendy EWM
  • BMC Cancer, Vol. 13, Issue 1
  • DOI: 10.1186/1471-2407-13-245

A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma: Anderson et al.
journal, June 2016

  • Anderson, Peter M.; Bielack, Stefan S.; Gorlick, Richard G.
  • Pediatric Blood & Cancer, Vol. 63, Issue 10
  • DOI: 10.1002/pbc.26087

Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation
journal, August 2003

  • Henriksen, Jørn; Aagesen, Trude H.; Maelandsmo, Gunhild M.
  • Oncogene, Vol. 22, Issue 34
  • DOI: 10.1038/sj.onc.1206671

Cancer genomics: why rare is valuable
journal, February 2015

  • Jamshidi, Farzad; Nielsen, Torsten O.; Huntsman, David G.
  • Journal of Molecular Medicine, Vol. 93, Issue 4
  • DOI: 10.1007/s00109-015-1260-8

The Architecture and Evolution of Cancer Neochromosomes
journal, November 2014


Allele-specific copy number analysis of tumors
journal, September 2010

  • Van Loo, P.; Nordgard, S. H.; Lingjaerde, O. C.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 39
  • DOI: 10.1073/pnas.1009843107

ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data: ascatNgs: Identifying Copy-number Alterations from Sequencing Data
journal, December 2016

  • Raine, Keiran M.; Van Loo, Peter; Wedge, David C.
  • Current Protocols in Bioinformatics, Vol. 56, Issue 1
  • DOI: 10.1002/cpbi.17

Mutational signatures of ionizing radiation in second malignancies
journal, September 2016

  • Behjati, Sam; Gundem, Gunes; Wedge, David C.
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12605

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
journal, October 2013

  • Behjati, Sam; Tarpey, Patrick S.; Presneau, Nadège
  • Nature Genetics, Vol. 45, Issue 12
  • DOI: 10.1038/ng.2814

Recurrent PTPRB and PLCG1 mutations in angiosarcoma
journal, March 2014

  • Behjati, Sam; Tarpey, Patrick S.; Sheldon, Helen
  • Nature Genetics, Vol. 46, Issue 4
  • DOI: 10.1038/ng.2921

Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma
journal, June 2013

  • Tarpey, Patrick S.; Behjati, Sam; Cooke, Susanna L.
  • Nature Genetics, Vol. 45, Issue 8
  • DOI: 10.1038/ng.2668

The landscape of cancer genes and mutational processes in breast cancer
journal, May 2012

  • Stephens, Philip J.; Tarpey, Patrick S.; Davies, Helen
  • Nature, Vol. 486, Issue 7403
  • DOI: 10.1038/nature11017

Mutational Processes Molding the Genomes of 21 Breast Cancers
journal, May 2012


Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
journal, May 2014

  • Fernanda Amary, M.; Ye, Hongtao; Berisha, Fitim
  • Cancer Medicine, Vol. 3, Issue 4
  • DOI: 10.1002/cam4.268

    Works referencing / citing this record:

    Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2
    journal, July 2019

    • Gardner, Heather L.; Sivaprakasam, Karthigayini; Briones, Natalia
    • Communications Biology, Vol. 2, Issue 1
    • DOI: 10.1038/s42003-019-0487-2

    Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2
    journal, July 2019

    • Gardner, Heather L.; Sivaprakasam, Karthigayini; Briones, Natalia
    • Communications Biology, Vol. 2, Issue 1
    • DOI: 10.1038/s42003-019-0487-2